Alentis Therapeutics
Alentis Therapeutics is a clinical-stage biotech company developing first-in-class anti-Claudin-1 antibodies and ADCs for cancer and fibrosis. Its pipeline includes oncology candidates such as ALE.P02/ALE.P03 and the fibrosis program Lixudebart (ALE.F02).
Company facts
- Founded
- 2019
- Employees
- 67
- Headquarters
- Switzerland
- CEO
- Mark Pruzanski
About
Alentis Therapeutics is a clinical-stage biotechnology company pioneering first-in-class antibody-drug conjugates (ADCs) and antibodies targeting Claudin-1 (CLDN1) for oncology and multi-organ fibrosis. CLDN1 is a previously unexploited target that plays a key role in the pathology of cancer and fibrotic disease. Alent…
Open positions
Senior Clinical Trial Leader Oncology
About this position The Senior Clinical Trial Leader Oncology acts as the face of Alentis towards external vendors and partners, fostering strong and collaborative relationships, and manages and executes all aspects of…
Sr. Director, Clinical Development Oncology
About this position The Senior Director, Clinical Development is responsible for providing medical leadership and strategic input across the clinical development programs of the company. Reporting to the Vice…
Chemist / Conjugation Expert
About this position The Chemist / Conjugation Expert acts as SME for the development, optimization, and scale-up of bioconjugation processes for our antibody-based therapeutic portfolio. As a key technical contributor,…
(Senior) Manager, CMC Program Lead
About this position The CMC Program Lead supports the development and execution of the CMC strategy for Alentis pipeline products, ensuring that CMC activities are aligned with overall program objectives and clinical…
Senior Documentation Specialist
About this position As the Senior Documentation Specialist, you ensure the effective management, quality, completeness, and inspection readiness of essential clinical trial documentation for assigned studies,…